TP53 and thyroid gland carcinoma: Collectively, these findings suggested that FAM27E3 promoted tumor progression by counteracting the p53 pathway, and its suppression can activate the p53-mediated tumor-suppressive effects, thereby impeding the proliferation and metastasis of thyroid cancer.